{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:46:41Z","timestamp":1767772001860,"version":"build-2065373602"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.rmr.2023.01.025","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:17:08Z","timestamp":1680517028000},"page":"324-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["La dysfonction chronique du greffon pulmonaire en 2022\u00a0: une entit\u00e9 mieux comprise et un d\u00e9fi th\u00e9rapeutique"],"prefix":"10.1016","volume":"40","author":[{"given":"P.","family":"Halitim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2023.01.025_bib0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report \u2013 2014; focus theme: retransplantation","volume":"33","author":"Yusen","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm1091","article-title":"Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity","volume":"10","author":"Moyron-Quiroz","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.chest.2018.08.1036","article-title":"The future of lung transplantation","volume":"155","author":"Young","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2023.01.025_bib0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2017.07.016","article-title":"The registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation report \u2013 2017; Focus theme: Allograft ischemic time","volume":"36","author":"Chambers","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment \u2013 A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0030","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.01.025_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1053-2498(02)00398-4","article-title":"Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria","volume":"21","author":"Estenne","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.86.6.824","article-title":"Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation","volume":"86","author":"Burke","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2023.01.025_bib0045","first-page":"713","article-title":"A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation","volume":"12","author":"Cooper","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0050","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2011.01.712","article-title":"Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction","volume":"30","author":"Sato","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0055","doi-asserted-by":"crossref","first-page":"W13","DOI":"10.2214\/AJR.17.19041","article-title":"High-resolution CT findings of obstructive and restrictive phenotypes of chronic lung allograft dysfunction: More than just bronchiolitis obliterans syndrome","volume":"211","author":"Hota","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TP.0b013e31822bf790","article-title":"Survival determinants in lung transplant patients with chronic allograft dysfunction","volume":"92","author":"Verleden","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.healun.2014.11.007","article-title":"Restrictive chronic lung allograft dysfunction: Where are we now?","volume":"34","author":"Verleden","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.rmed.2013.12.016","article-title":"Home spirometry as early detector of azithromycin refractory bronchiolitis obliterans syndrome in lung transplant recipients","volume":"108","author":"de Wall","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.healun.2009.01.014","article-title":"Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients","volume":"28","author":"Neurohr","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/TP.0b013e3182a6bae2","article-title":"Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation","volume":"97","author":"Verleden","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0085","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2016.03.022","article-title":"Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation","volume":"35","author":"Verleden","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0090","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3389\/fimmu.2019.01681","article-title":"Early identification of chronic lung allograft dysfunction: The need of biomarkers","volume":"10","author":"Tissot","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0095","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.tp.0000286040.85007.89","article-title":"Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide","volume":"84","author":"Garantziotis","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0100","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2013.06.017","article-title":"Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration","volume":"32","author":"Miller","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.thorsurg.2012.04.006","article-title":"Pulmonary infections following lung transplantation","volume":"22","author":"Witt","year":"2012","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.rmr.2023.01.025_bib0110","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.00128607","article-title":"Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?","volume":"31","author":"Vos","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.01.025_bib0115","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1097\/MCG.0b013e3181d47dc4","article-title":"Gastric juice from patients \u201con\u201d acid suppressive therapy can still provoke a significant inflammatory reaction by human bronchial epithelial cells","volume":"44","author":"Mertens","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0120","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1111\/ajt.12909","article-title":"Air pollution and the development of post-transplant chronic lung allograft dysfunction","volume":"14","author":"Bhinder","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0125","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.200409-1248OC","article-title":"Graft ischemic time and outcome of lung transplantation: a multicenter analysis","volume":"171","author":"Thabut","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0130","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.21037\/jtd.2017.07.81","article-title":"Chronic lung allograft dysfunction phenotypes and treatment","volume":"9","author":"Verleden","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.rmr.2023.01.025_bib0135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00007890-200007270-00022","article-title":"Elevated levels of interleukin-8\u00a0and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: pro-inflammatory role of bronchial epithelial cells. Munich Lung Transplant Group","volume":"70","author":"Elssner","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0140","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/TP.0000000000001215","article-title":"Chronic lung allograft dysfunction: A systematic review of mechanisms","volume":"100","author":"Royer","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1183\/09031936.98.12010082","article-title":"Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung","volume":"12","author":"Riise","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.01.025_bib0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0966-3274(02)00074-6","article-title":"Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity","volume":"10","author":"Devouassoux","year":"2002","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0966-3274(00)00029-0","article-title":"Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection","volume":"8","author":"Devouassoux","year":"2001","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2008.01.004","article-title":"Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance","volume":"19","author":"Fildes","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0165","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2012.04.007","article-title":"Bronchiolitis obliterans syndrome is associated with increased peripheral blood natural killer and natural killer T-like granzymes, perforin, and T-helper-type 1\u00a0pro-inflammatory cytokines","volume":"31","author":"Hodge","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0170","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/01.TP.0000088672.48259.F1","article-title":"Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation","volume":"76","author":"Oyaizu","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/TP.0b013e3181ac170f","article-title":"Bronchiolitis obliterans syndrome is associated with absence of suppression of peripheral blood Th1\u00a0pro-inflammatory cytokines","volume":"88","author":"Hodge","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0180","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1600-6143.2008.02321.x","article-title":"The role of the IL23\/IL17\u00a0axis in bronchiolitis obliterans syndrome after lung transplantation","volume":"8","author":"Vanaudenaerde","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0185","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.tp.0000281408.20686.cb","article-title":"T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome","volume":"84","author":"Mamessier","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0190","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1111\/j.1600-6143.2012.04191.x","article-title":"T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease","volume":"12","author":"Tiriveedhi","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.trre.2010.04.002","article-title":"T regulatory cells and transplantation tolerance","volume":"24","author":"Gorantla","year":"2010","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.rmr.2023.01.025_bib0200","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00007890-199904270-00012","article-title":"Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation","volume":"67","author":"Jaramillo","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0205","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.healun.2014.07.018","article-title":"De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation","volume":"33","author":"Morrell","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0210","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1378\/chest.112.5.1175","article-title":"FK 506 \u2018rescue\u2019 immunosuppression for obliterative bronchiolitis after lung transplantation","volume":"112","author":"Ross","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2023.01.025_bib0215","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.transproceed.2007.06.071","article-title":"Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome","volume":"39","author":"Borro","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.rmr.2023.01.025_bib0220","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jtcvs.2003.11.009","article-title":"International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection","volume":"127","author":"Sarahrudi","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rmr.2023.01.025_bib0225","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000004095","article-title":"Five-year outcome of an early everolimus-based quadruple immunosuppression in lung transplant recipients: Follow-up of the 4EVERLUNG Study","volume":"106","author":"Kneidinger","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0230","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/ajt.13835","article-title":"Everolimus versus mycophenolate mofetil de novo after lung transplantation: A prospective, randomized, open-label trial","volume":"16","author":"Strueber","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.healun.2014.06.001","article-title":"Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation","volume":"34","author":"Glanville","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.healun.2012.03.008","article-title":"Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation","volume":"31","author":"Treede","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0245","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.healun.2007.07.027","article-title":"A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation","volume":"26","author":"Hachem","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0250","first-page":"168121","article-title":"Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study","author":"Gerhardt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0255","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000122412.80864.43","article-title":"Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation","volume":"77","author":"Verleden","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0260","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200411-1537OC","article-title":"Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome","volume":"172","author":"Yates","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TP.0b013e31824db9da","article-title":"Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection","volume":"94","author":"Vos","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0270","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.healun.2010.05.023","article-title":"Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?","volume":"29","author":"Vos","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","article-title":"Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation","volume":"85","author":"Gottlieb","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0280","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/thoraxjnl-2014-205998","article-title":"A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post-lung transplantation","volume":"70","author":"Corris","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2023.01.025_bib0285","doi-asserted-by":"crossref","first-page":"e000465","DOI":"10.1136\/bmjresp-2019-000465","article-title":"Long-term effect of azithromycin in bronchiolitis obliterans syndrome","volume":"6","author":"Gan","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.rmr.2023.01.025_bib0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":"A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.01.025_bib0295","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1183\/09031936.00064807","article-title":"Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection","volume":"31","author":"Blondeau","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.01.025_bib0300","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.healun.2009.05.040","article-title":"Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective","volume":"28","author":"King","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0305","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14740\/gr1501","article-title":"Investigating defects of esophageal motility in lung transplant recipients","volume":"15","author":"Burlen","year":"2022","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.rmr.2023.01.025_bib0310","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1038\/ctg.2017.30","article-title":"Impaired esophageal motility and clearance post-lung transplant: risk for chronic allograft failure","volume":"8","author":"Tangaroonsanti","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0315","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1111\/j.1399-0012.2010.01243.x","article-title":"A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population","volume":"24","author":"Davis","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0320","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1067\/mtc.2003.166","article-title":"Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation","volume":"125","author":"Davis","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rmr.2023.01.025_bib0325","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.athoracsur.2004.04.044","article-title":"J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease","volume":"78","author":"Cantu","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rmr.2023.01.025_bib0330","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archsurg.2011.216","article-title":"Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation","volume":"146","author":"Hoppo","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.rmr.2023.01.025_bib0335","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.athoracsur.2011.04.035","article-title":"Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux","volume":"92","author":"Hartwig","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rmr.2023.01.025_bib0340","article-title":"Outcomes of partial fundoplication for GERD-related allograft decline after lung transplantation","author":"Kowalski","year":"2022","journal-title":"Surg Endosc"},{"key":"10.1016\/j.rmr.2023.01.025_bib0345","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/ajt.12155","article-title":"Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients","volume":"13","author":"Greer","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0350","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000431382","article-title":"Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: A 10-year single-centre analysis","volume":"90","author":"Del Fante","year":"2015","journal-title":"Respiration"},{"key":"10.1016\/j.rmr.2023.01.025_bib0355","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/TP.0b013e31818bc024","article-title":"Extracorporeal photopheresis after lung transplantation: A 10-year single-center experience","volume":"86","author":"Benden","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0360","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.healun.2012.05.002","article-title":"A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation","volume":"31","author":"Jaksch","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0365","first-page":"100913","article-title":"Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience","volume":"81","author":"Leroux","year":"2022","journal-title":"Respir Med Res"},{"key":"10.1016\/j.rmr.2023.01.025_bib0370","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.athoracsur.2016.09.107","article-title":"Two decades of lung retransplantation: A single-center experience","volume":"103","author":"Hall","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rmr.2023.01.025_bib0375","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1097\/TXD.0000000000000844","article-title":"Retransplantation outcomes at a large lung transplantation program","volume":"4","author":"Ren","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.rmr.2023.01.025_bib0380","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.healun.2022.06.022","article-title":"Epidemiology, risk factors, and outcomes of lung retransplantation: An analysis of the International Society for Heart and Lung Transplantation Thoracic Transplant Registry","volume":"41","author":"Harhay","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0385","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/ajt.13281","article-title":"Impact of CLAD phenotype on survival after lung retransplantation: A multicenter study","volume":"15","author":"Verleden","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0390","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/TP.0000000000001905","article-title":"Technique and outcomes of less invasive lung retransplantation","volume":"102","author":"Sommer","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0395","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1111\/ajt.15019","article-title":"Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series","volume":"18","author":"Vos","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0400","doi-asserted-by":"crossref","first-page":"143","DOI":"10.23736\/S0031-0808.19.03840-0","article-title":"Pirfenidone in chronic lung allograft dysfunction: a single cohort study","volume":"62","author":"Bennett","year":"2020","journal-title":"Panminerva Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0405","doi-asserted-by":"crossref","first-page":"00167","DOI":"10.1183\/23120541.00167-2019","article-title":"A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation","volume":"5","author":"Iacono","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmr.2023.01.025_bib0410","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajt.16858","article-title":"A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation","volume":"22","author":"Neurohr","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0415","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1600-6143.2004.00709.x","article-title":"The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation","volume":"5","author":"Fisher","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0420","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1164\/rccm.201604-0732OC","article-title":"Parametric response mapping as an imaging biomarker in lung transplant recipients","volume":"195","author":"Belloli","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0425","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1164\/rccm.202012-4528OC","article-title":"Radiographic graft surveillance in lung transplantation: prognostic role of parametric response mapping","volume":"204","author":"Belloli","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2023.01.025_bib0430","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1097\/TP.0000000000002771","article-title":"Lung density analysis using quantitative chest CT for early prediction of chronic lung allograft dysfunction","volume":"103","author":"Horie","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0435","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1007\/s00330-016-4643-5","article-title":"Restrictive allograft syndrome after lung transplantation: new radiological insights","volume":"27","author":"Dubbeldam","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0440","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2018.01.1306","article-title":"High circulating CD4+CD25hiFOXP3+ T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndrome","volume":"37","author":"Durand","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0445","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/ajt.14148","article-title":"Association of higher CD4+ CD25high CD127low, FoxP3+, and IL-2+ T cell frequencies early after lung transplantation with less chronic lung allograft dysfunction at two years","volume":"17","author":"Salman","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0450","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.TP.0000116565.86752.6B","article-title":"Regulatory CD4+ CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome","volume":"77","author":"Meloni","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2023.01.025_bib0455","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1111\/ajt.15532","article-title":"Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation","volume":"19","author":"Brosseau","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0460","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1111\/ajt.13798","article-title":"HLA matching at the Eplet level protects against chronic lung allograft dysfunction","volume":"16","author":"Walton","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.trim.2018.10.002","article-title":"HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant","volume":"51","author":"Walton","year":"2018","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.rmr.2023.01.025_bib0470","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/ajt.13305","article-title":"HLA-G*01:04-UTR3\u00a0recipient correlates with lower survival and higher frequency of chronic rejection after lung transplantation","volume":"15","author":"Di Cristofaro","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0475","doi-asserted-by":"crossref","first-page":"1910852","DOI":"10.1155\/2016\/1910852","article-title":"HLA-E(-)01:03\u00a0allele in lung transplant recipients correlates with higher chronic lung allograft dysfunction occurrence","volume":"2016","author":"Di Cristofaro","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.rmr.2023.01.025_bib0480","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ajt.12977","article-title":"Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study","volume":"15","author":"Brugi\u00e8re","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0485","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.healun.2022.01.013","article-title":"Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+ CD57+ ILT2+ T cells, selectively inhibited by the immune check-point HLA-G","volume":"41","author":"Brugi\u00e8re","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0490","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/ajt.17125","article-title":"Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction","volume":"22","author":"Bazemore","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0495","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.healun.2021.02.008","article-title":"Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)","volume":"40","author":"Keller","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0500","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2023.01.025_bib0505","doi-asserted-by":"crossref","first-page":"e0180281","DOI":"10.1371\/journal.pone.0180281","article-title":"The prognostic importance of CXCR3\u00a0chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation","volume":"12","author":"Shino","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2023.01.025_bib0510","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/ajt.17108","article-title":"Plasma CXCL9\u00a0and CXCL10\u00a0at allograft injury predict chronic lung allograft dysfunction","volume":"22","author":"Shino","year":"2022","journal-title":"Am J Transplant"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842523000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842523000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:24:18Z","timestamp":1760106258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842523000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0761842523000700"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2023.01.025","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La dysfonction chronique du greffon pulmonaire en 2022\u00a0: une entit\u00e9 mieux comprise et un d\u00e9fi th\u00e9rapeutique","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2023.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}